FOR IMMEDIATE RELEASE
ACS News Service Weekly PressPac: March 02, 2022
Mucus could explain why SARS-CoV-2 doesn’t spread easily from surfaces
“Mucins Inhibit Coronavirus Infection in a Glycan-Dependent Manner”
ACS Central Science
Early in the pandemic, many people fastidiously disinfected surfaces because laboratory studies predicted that SARS-CoV-2 could be easily transmitted in this way. Now, researchers reporting in ACS Central Science have found a possible explanation for why the predictions didn’t pan out: Sugar-decorated proteins in mucus could bind to the coronavirus on surfaces, keeping it from infecting cells. The findings could also hint at why some people are more vulnerable to COVID-19 than others.
Although experiments have shown that coronaviruses can persist on surfaces for days or weeks, it is now apparent that SARS-CoV-2 is much more likely to infect people through airborne droplets carrying the virus. The surface studies typically used viruses suspended in buffers or growth media, whereas in the real world, SARS-CoV-2 is coated in mucus when someone coughs or sneezes. With this in mind, Jessica Kramer and colleagues wondered if mucus components could explain the discrepancy between the lab predictions and reality. In addition to water, salts, lipids, DNA and other proteins, mucus contains proteins called mucins, which are heavily modified with sugar molecules known as glycans. To infect cells, the SARS-CoV-2 spike protein binds glycan molecules with sialic acid at their ends on the cell surface. So, the researchers wondered if the coronavirus also recognizes sialic acid-containing glycans in mucins. If the spike protein is already bound to glycans in mucus, perhaps it couldn’t bind to the ones on cells, they reasoned.
For safety reasons, the researchers chose to study a human coronavirus called OC43, which evolved relatively recently from a cow coronavirus and causes mostly mild respiratory infections. The team deposited droplets of the virus in buffer or growth medium supplemented with 0.1–5% mucins, which corresponds to the concentration range of mucins found in nasal mucus and saliva, onto a plastic surface and let the drops dry. Then, they rehydrated the viral residue and measured its ability to infect cells. In comparison to the buffer or growth medium alone, the solutions supplemented with mucins were dramatically less infectious. The team also tested steel, glass and surgical mask surfaces, finding similar results.
The researchers showed that, as the droplets dried, mucins moved to the edge and concentrated there in a coffee-ring effect, bringing the virus with them. This brought mucins and virus particles close together, where they could more easily interact. Cutting off sialic acid glycans from mucins with an enzyme eliminated viral binding and destroyed the glycoproteins’ protective effect. Because SARS-CoV-2, like OC43, binds to sialic acid glycans on cell surfaces, mucins would also likely reduce its infectivity, the researchers suspect. The levels and types of sugar molecules on mucins can vary with diet and certain diseases, which could possibly explain the vulnerability of certain people to COVID-19, they say.
The authors acknowledge funding from the National Science Foundation.
###
The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.
Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.
Media Contact
ACS Newsroom
newsroom@acs.org
###
La sociedad American Chemical Society (ACS) es una organización sin fines de lucro fundada en 1876 y aprobada por el Congreso de los Estados Unidos. La ACS se ha comprometido a mejorar la vida de todas las personas mediante la transformación del poder de la química. Su misión es promover el conocimiento científico, empoderar a la comunidad global y defender la integridad científica, y su visión es un mundo construido basándose en la ciencia. La Sociedad es líder mundial en la promoción de la excelencia en la educación científica y en el acceso a información e investigación relacionadas con la química a través de sus múltiples soluciones de investigación, publicaciones revisadas por expertos, conferencias científicas, libros electrónicos y noticias semanales periódicas de Chemical & Engineering News. Las revistas de la ACS se encuentran entre las más citadas, las más fiables y las más leídas en la literatura científica; sin embargo, la propia ACS no realiza investigación química. Como líder en soluciones de información científica, su división CAS se asocia con innovadores internacionales para acelerar los avances mediante la preservación, la conexión y el análisis de los conocimientos científicos del mundo. Las sedes principales de la ACS se encuentran en Washington, D.C., y Columbus, Ohio.
Los periodistas registrados pueden suscribirse al portal de noticias para periodistas de ACS en EurekAlert! para acceder a comunicados de prensa públicos y retenidos. Para consultas de los medios, comuníquese con newsroom@acs.org.
Nota: ACS no realiza investigaciones, pero publica y divulga estudios científicos revisados por expertos.

View larger image